TRex Bio, Inc. (TRXB): what it filed
Regulatory filings for TRex Bio, Inc. (TRXB), each one linked back to the document it was parsed from, and each score stating the inputs it was built from.
Streams covered here: 5%+ stake filing (13d/g).
Recent filings
2026-10-16 - 5%+ stake filing (13D/G) - score 50/100
holder: PFIZER INC · intent: New passive 5%+ stake (13G) · is amendment: Original filing
2026-10-16 - 5%+ stake filing (13D/G) - score 95/100
holder: ELI LILLY & Co · intent: New activist stake (13D) - investor with intent to influence - 19.9% of class · is amendment: Original filing
2026-10-16 - 5%+ stake filing (13D/G) - score 95/100
holder: SV Biotech Crossover Opportunities Fund LP · intent: New activist stake (13D) - investor with intent to influence - 7.0% of class · is amendment: Original filing
2026-10-15 - 5%+ stake filing (13D/G) - score 50/100
holder: Johnson & Johnson Innovation - JJDC, Inc. · intent: New passive 5%+ stake (13G) · is amendment: Original filing
Being straight about what this is
Not advice. This page reports what a public filing says and links to it. It draws no conclusion from that.
Refreshed once a night, and some publishers are slower by nature: congressional trades weekly, institutional holdings quarterly.
Names come from the filing. Where a person is named, that name is a required disclosure field in the public document, and the link above goes to it.
DataSignals Lab publishes data and research. Informational only, not investment advice, not an offer or solicitation. Every figure links back to the official filing so you can verify it yourself.